-
The number of women over the age of 50 in China is estimated to increase to more than 280 million by 2030 (1). With an increase in age, the mortality rate of people aged 50 and above in China is rising rapidly, and the prevalence of chronic diseases in middle-aged and older people (45 years old and above) is much higher than that in other age groups (2). With the aging of the population, the health of menopausal and older women has become prioritized. The purpose of this study is to investigate the health status of menopausal and older women in different areas of China through a survey of women aged 50–70 years to provide a scientific basis for promoting the health of women. A cross-sectional survey involving 5,049 women aged 50–70 years was conducted across eastern, central, and western China. The main result of this study showed that the health problems of menopausal and older women in the western region and rural areas were more prominent. Taking effective measures is necessary to narrow the gap in health between different age groups of women and different regions.
This study was a survey of women aged 50–70 years in the National Survey of Women’s Health conducted in 2018. The national survey was conducted to represent the three socioeconomic regions of China: eastern (Jiangsu and Shandong provinces), central (Hunan and Anhui provinces), and Western (Shaanxi and Sichuan provinces). In each province, one urban and one rural area were selected as investigation sites. A total of 5,049 women aged 50–70 years were selected by multistage stratified random cluster sampling and completed face-to-face interview questionnaires in the national survey. This study analyzed the relevant survey results of women aged 50–70 years. The reported chronic diseases and gynecological diseases in this study were required to be diagnosed by secondary hospitals or above.
The average age of the respondents was 58.94±6.195 years. Among the respondents, 1,703 (33.7%) came from the eastern region, 1,667 (33.0%) from the central region, and 1,679 (33.3%) from the western region. Most respondents (85.5%) were married, and 11.7% were widowed. The main occupation of the cohort was farming, accounting for 55.2%, followed by retirees, accounting for 17.1%. Most of the participants (55.0%) had only a primary school education or were illiterate, followed by those who had junior and senior high school educations, accounting for 42.0%. Only 3.0% had junior college degrees or higher. The majority (89.9%) of the women were postmenopausal.
Among the 5,049 women, 55.1% (95% CI: 53.7%–56.5%) reported that they had chronic diseases diagnosed by the hospital. The proportions of women suffering from chronic diseases in the western region (58.5%, 95% CI: 56.2%–60.9%) and rural areas (57.8%, 95% CI: 55.9%–59.7%) were higher than that in the eastern (51.8%, 95% CI: 49.4%–54.2%), central (55.0%, 95% CI: 52.6%–57.4%), and urban areas (52.5%, 95% CI: 50.5%–54.4%). There were differences between different regions and areas (p<0.001). The proportion of self-reported overweight and obesity was the highest (46.5%, 95% CI: 45.0%–47.9%). The prevalence of overweight and obesity among women in the eastern region (55.8%, 95% CI: 53.3%–58.2%) was significantly higher than the western (45.4%, 95% CI: 42.7%–48.0%) and central regions (37.8%, 95% CI: 35.4%–40.3%) (p<0.001). The prevalence of cardiovascular disease (11.9%, 95% CI: 10.4%–13.5%), osteoporosis (10.9%, 95% CI: 9.4%–12.4%), and kidney disease (2.6%, 95% CI: 1.9%–3.4%) among women in the western region were significantly higher than those in the eastern and central regions (p<0.005). The prevalence of osteoarthrosis (15.0%, 95% CI: 13.6%–16.4%) in rural women was higher than that of urban women (11.4%, 95% CI: 10.1%–12.6%). However, the prevalence of osteoporosis (9.8%, 95% CI: 8.6%–11.0%), oral disease (2.6%, 95% CI: 2.0%–3.2%), and thyroid disease (1.6%, 95% CI: 1.1%–2.1%) in urban women were higher than those in rural women (5.7%, 95% CI: 4.8%–6.6%, 1.3%, 95% CI: 0.9%–1.8%, and 0.8%, 95% CI: 0.4%–1.1%, respectively)(p<0.01)(Table 1).
Chronic diseases Total
N (%, 95% CI)Regions Area Type Eastern Central Western χ2 p Urban Rural χ2 p N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) Having one or more chronic diseases 2,783
(55.1, 53.7−56.5)883
(51.8, 49.4−54.2)917
(55.0, 52.6−57.4)983
(58.5, 56.2−60.9)15.341 0.000 1,324
(52.5, 50.5−54.4)1,459
(57.8, 55.9−59.7)14.236 0.000 Overweight and obesity 2,047
(46.5, 45.0−47.9)870
(55.8, 53.3−58.2)571
(37.8, 35.4−40.3)606
(45.4, 42.7−48.0)111.642 0.000 1,115
(46.0, 44.0−47.9)932
(47.1, 44.9−49.3)3.353 0.187 Hypertension 1437
(28.5, 27.2−29.7)479
(28.1, 26.0−30.3)509
(30.5, 28.3−32.7)449
(26.7, 24.6−28.9)6.048 0.049 699
(27.7, 26.0−29.5)738
(29.2, 27.4−31.0)1.415 0.234 Osteoarthrosis 665
(13.2, 12.2−14.1)196
(11.5, 10.0−13.0)213
(12.8, 11.2−14.4)256
(15.2, 13.5−17.0)10.667 0.005 287
(11.4, 10.1−12.6)378
(15.0, 13.6−16.4)14.217 0.000 Diabetes 517
(10.2, 9.4−11.1)183
(10.7, 9.3−12.2)189
(11.3, 9.8−12.9)145
(8.6, 7.3−10.0)7.359 0.025 244
(9.7, 8.5−10.8)273
(10.8, 9.6−12.0)1.774 0.183 Cardiovascular diseases 496
(9.8, 9.0−10.6)151
(8.9, 7.5−10.2)145
(8.7, 7.3−10.1)200
(11.9, 10.4−13.5)12.408 0.002 250
(9.9, 8.7−11.1)246
(9.7, 8.6−10.9)0.041 0.839 Osteoporosis 392
(7.8, 7.0−8.5)72
(4.2, 3.3−5.2)137
(8.2, 6.9−9.3)183
(10.9, 9.4−12.4)53.266 0.000 247
(9.8, 8.6−11.0)145
(5.7, 4.8−6.6)28.906 0.000 Oral diseases 99
(2.0, 1.6−2.3)16
(0.9, 0.5−1.4)42
(2.5, 1.8−3.3)41
(2.4, 1.7−3.2)13.969 0.001 65
(2.6, 2.0−3.2)34
(1.3, 0.9−1.8)9.939 0.000 Kidney disease 75
(1.5, 1.2−1.8)14
(0.8, 0.4−1.3)17
(1.0, 0.5−1.5)44
(2.6, 1.9−3.4)22.376 0.000 36
(1.4, 1.0−1.9)39
(1.5, 1.1−2.0)0.118 0.731 Thyroid disease 60
(1.2, 0.9−1.5)22
(1.3, 0.8−1.8)21
(1.3, 0.7−1.8)17
(1.0, 0.5−1.5)0.670 0.715 40
(1.6, 1.1−2.1)20
(0.8, 0.4−1.1)6.771 0.009 Table 1. Comparison of the prevalence of self-reported chronic diseases among women aged 50–70 years old by regions and area type, 2018, China.
Of the participating women, 39.6% (95% CI: 38.3%–40.9%) reported that they had gynecological diseases diagnosed by the hospital. The proportion of women suffering from gynecological diseases in the central (42.6%, 95% CI: 40.2%–45.0%), western (42.7%, 95% CI: 40.3%–45.1%), and rural areas (42.2%, 95% CI: 40.3%–44.1%) was higher than that in the eastern (33.6%, 95% CI: 38.3%–40.9%) and urban areas (37%, 95% CI: 35.1%–38.9%) (p<0.001)(Table 2).
Gynecological diseases Total
N (%, 95% CI)Regions Area Type Eastern Central Western χ2 p Urban Rural χ2 p N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) Having one or more gynecological disease 1,999
(39.6, 38.3−40.9)572
(33.6, 31.4−5.9)710
(42.6, 40.2−45.0)717
(42.7, 40.3−45.1)38.739 0.000 933
(37.0, 35.1−38.9)1,066
(42.2, 40.3−44.1)14.388 0.000 Vaginitis 1,232
(24.4, 23.2−25.6)299
(17.6, 15.7−19.4)440
(26.4, 24.3−28.5)493
(29.4, 27.2−31.5)69.239 0.000 500
(19.8, 18.3−21.4)732
(29.0, 27.2−30.7)57.425 0.000 Cervicitis 602
(11.9, 11.0−12.8)123
(7.2, 6.0−8.5)277
(16.6, 14.8−18.4)202
(12.0, 10.5−13.6)70.819 0.000 257
(10.2, 9.0−11.4)345
(13.7, 12.3−15.0)14.487 0.000 Pelvic inflammation 361
(7.1, 6.4−7.9)73
(4.3, 3.3−5.2)134
(8.0, 6.7−9.3)154
(9.2, 7.8−10.6)33.357 0.000 168
(6.7, 5.7−7.6)193
(7.6, 6.6−8.7)1.833 0.176 Urinary leakage/incontinence 583
(11.5, 10.7−12.4)107
(6.3, 5.1−7.4)244
(14.6, 12.9−16.3)232
(13.8, 12.2−15.5)70.263 0.000 243
(9.6, 8.5−10.8)340
(13.5, 12.1−14.8)18.116 0.000 Benign tumor 511
(10.1, 9.3−11.0)205
(12.0, 10.5−13.6)156
(9.4, 8.0−10.8)150
(8.9, 7.6−10.3)10.545 0.000 284
(11.3, 10.0−12.5)227
(9.0, 7.9−10.1)7.150 0.000 Malignant tumor 43
(0.9, 0.6−1.1)14
(0.8, 0.4−1.3)15
(0.9, 0.4−1.4)14
(0.8, 0.4−1.3)0.070 0.966 27
(1.1, 0.7−1.5)16
(0.6, 0.3−0.9)2.851 0.091 Table 2. Comparison of the prevalence of self-reported gynecological diseases among women aged 50–70 years old by regions and area type, 2018, China
Among the self-reported gynecological diseases, the prevalence of vaginitis was the highest (24.4%, 95% CI: 23.2%–25.6%). The prevalence of vaginitis (29.4%, 95% CI: 27.2%–31.5%) and pelvic inflammation (9.2%, 95% CI: 7.8%–10.6%) in the western region were significantly higher than those in the eastern region (p<0.001). The prevalence of urinary incontinence in the central region (14.6%, 95% CI: 12.9%–16.3%) was significantly higher than that in the eastern region (6.3%, 95% CI: 5.1%–7.4%) (p<0.001). The prevalence of benign tumors in the eastern region (12.0%, 95% CI: 10.5%–13.6%) was significantly higher than that in the western region (8.9%, 95% CI: 7.6%–10.3%) (p<0.001). The prevalence of vaginitis (29.0%, 95% CI: 27.2%–30.7%) and cervicitis (13.7%, 95% CI: 12.3%–15.0%) in rural women were significantly higher than those in urban women (19.8%, 95% CI: 18.3%–21.4% and 10.2%, 95% CI: 9.0%–11.4%, respectively)(p<0.001)(Table 2).
The prevalence of hypertension, diabetes, cardiovascular disease, osteoporosis, and urinary incontinence increased with age, and there were significant differences among different age groups (p<0.001). The prevalence of vaginitis, cervicitis and gynecological benign tumor was the highest in the age group of 50–54 years old. The prevalence of vaginitis and cervicitis decreased with increasing age, and there were significant differences among different age groups (p<0.001)(Table 3).
Health status 50–54 55–59 60–64 65−70 χ2 p χ2trend p N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) N (%, 95% CI) Chronic diseases 740 (46.3, 43.9−48.8) 538 (50.6, 47.6−53.6) 673 (57.6, 54.8−60.5) 832 (68.2, 65.6−70.8) 145.706 0.000 140.620 0.000 Overweight and obesity 672 (46.4, 43.8−49.0) 460 (47.6, 44.4−50.7) 466 (46.6, 43.5−49.7) 449 (45.3, 42.2−48.4) 1.017 0.797 0.315 0.574 Hypertention 327 (20.5, 18.5−22.5) 281 (26.4, 23.8−29.1) 348 (29.8, 27.1−32.4) 481 (39.4, 36.7−42.2) 125.183 0.000 120.818 0.000 Osteoarthrosis 197 (12.3, 10.7−14.0) 127 (11.9, 10.0−13.9) 160 (13.7, 11.7−15.7) 181 (14.8, 12.8−16.8) 5.596 0.133 4.599 0.032 Diabetes 81 (5.1, 4.0−6.1) 98 (9.2, 7.5−11.0) 162 (13.9, 11.9−15.8) 176 (14.4, 12.5−16.4) 87.522 0.000 81.882 0.000 Cardiovascular diseases 73 (4.6, 3.5−5.6) 84 (7.9, 6.3−9.5) 128 (10.9, 9.2−12.7) 211 (17.3, 15.2−19.4) 132.718 0.000 128.679 0.000 Osteoporosis 82 (5.1, 4.1−6.2) 72 (6.8, 5.3−8.3) 91 (7.8, 6.2−9.3) 147 (12.0, 10.2−13.9) 48.159 0.000 43.954 0.000 Oral diseases 22 (1.4, 0.8−1.9) 17 (1.6, 0.8−2.4) 29 (2.5, 1.6−3.4) 31 (2.5, 1.7−3.4) 7.329 0.062 6.635 0.010 Kidney disease 21 (1.3, 0.8−1.9) 8 (0.8, 0.2−1.3) 20 (1.7, 1.0−2.5) 26 (2.1, 1.3−2.9) 8.100 0.044 4.450 0.035 Thyroid disease 23 (1.4, 0.9−2.0) 9 (0.8, 0.3−1.4) 17 (1.5, 0.8−2.1) 11 (0.9, 0.4−1.4) 3.477 0.324 0.778 0.378 Gynecological diseases 765 (47.9, 45.4−50.4) 421 (36.8, 34.0−39.6) 441 (37.7, 34.9−40.5) 372 (30.5, 27.9−33.1) 90.063 0.000 86.622 0.000 Vaginitis 451 (28.2, 26.0−30.5) 248 (23.3, 20.8−25.9) 268 (22.9, 20.5−25.3) 265 (21.7, 19.4−24.0) 19.551 0.000 16.408 0.000 Cervicitis 234 (14.7, 12.9−16.4) 138 (13.0, 11.0−15.0) 125 (10.7, 8.9−12.5) 105 (8.6, 7.0−10.2) 26.927 0.000 26.835 0.000 Pelvic inflammation 128 (8.0, 6.7−9.3) 90 (8.5, 6.8−10.1) 72 (6.2, 4.8−7.5) 71 (5.8, 4.5−7.1) 9.557 0.000 7.366 0.007 Urinary leakage/incontinence 178 (11.1, 9.6−12.7) 101 (9.5, 7.7−11.3) 128 (10.9, 9.2−12.7) 176 (14.4, 12.5−16.4) 14.917 0.000 6.944 0.008 Benign tumor 219 (13.7, 12.0−15.4) 99 (9.3, 7.6−11.1) 119 (10.2, 8.4−11.9) 74 (6.1, 4.7−7.4) 45.479 0.000 38.896 0.000 Malignant tumor 16 (1.0, 0.5−1.5) 8 (0.8, 0.2−1.3) 13 (1.1, 0.5−1.7) 6 (0.5, 0.1−0.9) 3.360 0.339 1.145 0.285 Table 3. Comparison of the health status among women aged 50−70 years old by different age groups, 2018, China.
HTML
Citation: |